Wolfgang Hierneis β€” investor profile photo

Wolfgang Hierneis

Experienced consultant and interim manager for SMEs and start-ups - M&A, Turnaround, Finance, Strategy and Controlling

πŸ“ Stadt Hamburg, Hamburg, GermanyπŸ”„ Updated November 2026πŸ’Ό 3 investmentsπŸ“… 21 years investingπŸ—“ Last invested Sep 2014
Operator-angel🌍 Germany
3
Total investments
1
Early stage
0
Mid stage
0
Late stage
21y
Years active

Portfolio

1 investments Β· sorted by recency
All investments
Early stage
Mid stage
Late stage
Shareholder
Nov 2005
MediaAnalyzer, a global pioneer in ad optimization helps companies increase sales through marketing research and consulting. With offices in Hamburg and New York and representatives in the UK, Switzerland, Belgium and South-East Asia, we are active in the international market. Since 2003 MediaAnalyzer has helped companies, ranging in size from Fortune 500 to small-medium size businesses, optimize their advertising campaigns, packaging, POS, web sites, out of home advertising and TV commercials. MediaAnalyzer's proprietary services, AttentionTracking and EmotionTracking, combined with customized surveys provide engaging, insightful and actionable results. Conducting research online allows for larger and more geographically diverse samples, faster turnaround (10-days)-all at a lower cost than traditional lab based research.
early stageMarket Research
Experience Β· 6 entries
All (6)
Investments (3)
Founder (1)
2014
Lipozyt Marker UG
Shareholder
Sep 2014
Co-Founder and Managing Director
Jul 2014
π’Žπ‘Ήπ‘΅π‘¨-𝒃𝒂𝒔𝒆𝒅 π’…π’Šπ’‚π’ˆπ’π’π’”π’•π’Šπ’„π’” 𝒂𝒏𝒅 π’•π’‰π’†π’“π’‚π’‘π’†π’–π’•π’Šπ’„π’” 𝒇𝒐𝒓 π’Žπ’†π’•π’‚π’ƒπ’π’π’Šπ’„ π’…π’Šπ’”π’†π’‚π’”π’†π’” We are pioneering the use of the mRNAs of the subcutaneous adipose tissue (SAT) for medical purposes. The SAT is a metabolically highly active organ and is directly involved in the development of metabolic diseases. Its activity is controlled by special mRNAs. These mRNAs provide a highly effective new starting point for the diagnosis and therapy of these diseases. Through our innovations, we can easily analyze the complex mRNA-patterns of a patients SAT. We have developed diagnostic tests for the personalized therapy-planning of metabolic patients. In the future, we will additionally target mRNA-based personalized therapy concepts for the recovery of SAT. We develop our patented products together with renowned university partners.
2012
Project Key GmbH
Partner / Shareholder
Aug 2012
2005
Shareholder
Nov 2005
MediaAnalyzer, a global pioneer in ad optimization helps companies increase sales through marketing research and consulting. With offices in Hamburg and New York and representatives in the UK, Switzerland, Belgium and South-East Asia, we are active in the international market. Since 2003 MediaAnalyzer has helped companies, ranging in size from Fortune 500 to small-medium size businesses, optimize their advertising campaigns, packaging, POS, web sites, out of home advertising and TV commercials. MediaAnalyzer's proprietary services, AttentionTracking and EmotionTracking, combined with customized surveys provide engaging, insightful and actionable results. Conducting research online allows for larger and more geographically diverse samples, faster turnaround (10-days)-all at a lower cost than traditional lab based research.
early stageMarket Research
1998
Wolfgang Hierneis Wirtschaftsberatung
Principal
Jul 1998
Show all 6 entries ↓
Investment activity
2005–2014 Β· 3 investments
200512012120141
Recent (last 2 years)Earlier
Investor lists
Lists that match Wolfgang's portfolio